News | Pediatric Imaging | November 29, 2016

Collaboration aims to help doctors interpret pediatric brain images faster and more accurately

Boston Children's Hospital, GE Healthcare, pediatric brain disorders, decision support platform

November 29, 2016 — Boston Children's Hospital and GE Healthcare announced a collaboration to develop and commercialize digital solutions to advance the diagnosis and treatment of specific childhood diseases – starting with diseases that affect the brain. The first project, detailed at the 102nd annual meeting of the Radiological Society of North America, Nov. 27-Dec. 1 in Chicago, seeks to improve diagnostic accuracy in pediatric brain scans by providing real-time contextual information at the time and place the radiologist needs it.  

Every day, tens of thousands of children undergo medical imaging. At Boston Children's alone, nearly 1,000 imaging studies are performed each day. For general radiologists and pediatric imagers alike, the rapid changes in the body that occur as part of normal childhood development can pose challenges to accurately differentiate normal from abnormal. Keeping up with the ever-growing litany of specific diagnoses can frustrate even the most experienced of radiologists. 

Leveraging the software expertise of GE Healthcare, the high-volume computing power of the GE Health Cloud and the clinical knowledge of radiologists at Boston Children's, the two organizations are working to develop a decision support platform that is intended to help distinguish the large variability in brain magnetic resonance imaging (MRI) scans.  

The system will be pre-loaded with normative reference scans from young children of different ages for doctors worldwide to use as a benchmark when reading scans of pediatric patients.

"Interpreting pediatric brain scans requires a specific understanding of the developing brain," said Richard Robertson, M.D., radiologist-in-chief at Boston Children's. "Since most pediatric imaging is not performed in children's hospitals by specialists, this new digital tool, once available, will provide non-specialists with access to knowledge and expertise to help effectively diagnose children. We believe that by providing decision support at the time of interpretation, we can improve both the confidence and performance of the interpreting radiologist."

Ad hoc image databases are often limited to the pediatric departments of major academic institutions. General radiologists without access to such databases lack large reference points and context, which could lead to potential misdiagnosis. Changes in myelination occurring during the first few years of life are particularly likely to be confused with disease states or, conversely, may lead to misinterpretation of the exam as normal for the patient when the abnormality is symmetric in the brain.

"Pediatric brain scans of children under the age of four can be particularly tricky to read because the brain is rapidly developing during this period of childhood," said Sanjay Prabhu, MBBS, pediatric neuroradiologist at Boston Children's. "Since pediatric neuroradiologists are very scarce, we approached GE Healthcare to collaborate on the development of digital tools to help physicians of varying expertise read the scans."

During infancy and childhood, complicated disorders, especially when affecting the brain symmetrically, may be misinterpreted as normal brain maturation. Conversely, normal expected developmental changes are sometimes misinterpreted as pathologic, leading to unnecessary follow-up imaging or other diagnostic tests, which can be expensive, stressful and inconvenient to the child and family.

Boston Children's is participating via its Innovation and Digital Health Accelerator (IDHA), led by Jean Mixer, vice president of strategy and digital health, and John Brownstein, Ph.D., chief innovation officer. IDHA seeks to enable clinicians anywhere in the world to access the hospital's expertise and data in rare and complex pediatric care through digital tools. 

For more information: www.gehealthcare.com


Related Content

News | FDA

March 6, 2024 — Lantheus Holdings, Inc. (Lantheus), a radiopharmaceutical company, has announced that the U.S. Food and ...

Time March 06, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

February 9, 2024 — Multiple sclerosis (MS) is a neurological disease that usually leads to permanent disabilities. It ...

Time February 09, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

January 26, 2024 — InkSpace Imaging, a leader in innovative diagnostic medical device technology, is proud to announce ...

Time January 26, 2024
arrow
Sponsored Content | Case Study | Digital Radiography (DR)

Playing sports is good for all ages: it helps participants stay in shape, learn how to organize their time, and help ...

Time January 15, 2024
arrow
News | Artificial Intelligence

November 21, 2023 — A newly developed artificial intelligence (AI) system that analyzes specialized MRIs of the brain ...

Time November 21, 2023
arrow
News | Radiopharmaceuticals and Tracers

August 29, 2023 — Mammograms are an essential part of preventive healthcare, and when an initial review reveals a ...

Time August 29, 2023
arrow
News | Artificial Intelligence

August 23, 2023 — With the goal of ensuring access to safe and clinically useful AI for all pediatric patients, the ...

Time August 23, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

August 18, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR), an ...

Time August 18, 2023
arrow
Feature | Radiology Business | By Cedric Wilson, MBA, RT(R)(MR)

There are many ways to serve to make a meaningful impact in the lives of others. This applies to my work in the ...

Time July 13, 2023
arrow
Subscribe Now